Matrix carboxy glutamic acid protein serum level in type 2 diabetes mellitus patients with coronary artery disease  by unknown
hyperintensities were scored according to the modiﬁed Scheltens score.
Signiﬁcance level for the used tests is p= 0.05.
Results: The mean age was 68.8  3.4 years old. The distribution of
gender, smoking and dyslipidemia among the 4 groups was not signif-
icant. The hypertension duration, oﬃce and 24-h ABPM BP measure-
ments and MRI score varied signiﬁcantly between the 4 groups
(p < 0.0005). The hypertension duration and the average awake sys-
tolic blood pressure had the stronger impact on the MMSE class of
the patient (R2 = 0.87, p < 0.0005). Classifying the patients into con-
trolled and uncontrolled hypertensives, we had a higher percentage
of uncontrolled BP in every cognitive impairment class. Only 1 patient
with normal cognitive function had an uncontrolled hypertension.
MMSE score has a sensitivity and speciﬁcity of 94% and 83% respec-
tively in the prediction of uncontrolled hypertension.
Conclusion: We conclude that MMSE is a simple test to run in
clinic and can give an idea about the degree of structural damage
caused to the brain; and hence predict whether or not the patient’s
BP is well controlled. This would not replace the 24-hour ABPM
but may help guide the clinicians to request this 24-hour
monitoring.
http://dx.doi.org/10.1016/j.ehj.2013.12.038
Low-dose warfarin in high-risk pregnant patients with mechanical valves:
A randomized clinical trial
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Toema a, Hemat Allam b
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Background: Low-dose Warfarin (LDW) throughout pregnancy was
suggested to provide safe and eﬀective anticoagulation in pregnant
patients with mechanical heart valve prosthesis (MHVP). We aimed
to study its rate of failure in achieving target INR of those patients.
Methods: Group A: 100 pregnant patients with mitral (+aortic; 24%)
MHVP were randomized in a 3:1 ratio, to either receive LDW (<5 mg/
day) or phenindione (<100 mg/day) throughout pregnancy; respec-
tively. Group B: 100 females in the child-bearing period with mitral
(+aortic; 19%) MHVP were randomized similarly and followed same
dosage limits. Both groups targeted an INR of 2.5–3.5. Patients failing
to reach this target were shifted to the other oral anticoagulant (OA).
Aspirin (100 mg/day) was supplemented on the 2nd trimester / 4th fol-
low-up month (Group B).
Results: Primary outcome: 20 patients in Group A (26.7%; 16.7–
36.7%; P= 0.003) and 4 patients in Group B (5.3%; 0.23–10.37%;
P= 0.5) failed to achieve target INR; all being on LDW. Secondary
outcomes: Group A received larger doses of either OA (P < 0.0001)
achieved lower INR values (P < 0.0001) and had higher failure rates,
compared to Group B (relative risk: 5; 1.8–13.9); (P= 0.001). We
had no patient mortality or fetal embryopathy but 9 spontaneous
abortions and 2 stillbirths related to insigniﬁcantly higher OA doses
and lower INR achieved (P= 0.039).
Conclusions: LDW may be insuﬃcient to reach INR target, especially
in high-risk pregnant patients with MHVP. Phenindione can oﬀer an
eﬀective and probably safe alternative. NCT01758640.
http://dx.doi.org/10.1016/j.ehj.2013.12.039
Major bleeding in acute coronary syndromes: Incidence, predictors and
prognostic value
Walid Ammar, Hossam Kandil, Osama Abdel Rehim
Cardiology Department, Cairo University, Egypt.
Background: Hemorrhagic complications have been strongly linked
with subsequent morbidity and mortality in patients with acute coro-
nary syndromes (ACS).
Objectives: To determine the incidence and predictors of major bleed-
ing and its impact on outcomes, including mortality, in patients with
ACSs.
Methods: Patients (n_ 200) with ACS, clinical data, management strat-
egies, complications and outcome were reported in case report form.
Factors associated with major bleeding were identiﬁed using logistic
regression analysis and impact of major bleeding on outcomes, includ-
ing mortality was reported.
Results: Bleeding occurred in 41 pts (20.5%), and was classiﬁed as nui-
sance (15 pts, 7.5%), minor (21pts, 10.5%) and major bleeding (5pts,
2.5%). Advanced age (p= 0.02), interventional coronary procedures
(p= 0.001), low BMI (p= 0.047), Clopidogrel loading > 300 mg
(p= 0.006) and renal insuﬃciency (p= 0.04) were independently
associated with a higher risk of major bleeding. Bleeding was indepen-
dently associated with an increased risk of hospital and 30 day inci-
dence of death, MI and stroke (p= 0.03). Patients with major
bleeding showed higher frequency of blood transfusion (p= 0.0001),
discontinuation of antithrombotics (p= 0.0001), mortality
(p= 0.0001), and MI (p= 0.02). Haemoglobin decrease at cut oﬀ
point of 3.4 gm predicted major complications with sensitivity 91%
and speciﬁcity 88% with AUC of 0.9 and (p= 0.0001).
Conclusions: Major bleeding is a powerful independent predictor of in-
hospital and 30 day mortality in patients with ACS. Advanced age,
renal insuﬃciency, high clopidogrel loading and invasive coronary
procedures are independent risk factors for major bleeding in ACS
patients.
http://dx.doi.org/10.1016/j.ehj.2013.12.040
Matrix carboxy glutamic acid protein serum level in type 2 diabetes
mellitus patients with coronary artery disease
Background: Poor glycemic control is a very strong independent pre-
dictor of vascular calciﬁcation which is a well known manifestation
of atherosclerosis and plays a signiﬁcant role in the development of
cardiovascular complications in systemic disease. Diﬀerent factors
for initiating vascular calciﬁcation are proposed, these include matrix
gamma carboxy glutamate protein (MGP), osteopontin and fetuin-
A. MGP is a vitamin K-dependent extracellular matrix protein that
binds to calcium ions and is involved in the prevention of vascular
calciﬁcation.
Aim: The present work aimed at evaluating serum level of matrix car-
boxy glutamic acid protein in type two diabetes mellitus male patients
with coronary artery disease.
Subjects and methods: The present study was conducted on eighty
male patients divided into four main groups. The control group
included 20 apparently healthy males, the ischemic group included
20 male patients suﬀered from ischemic heart disease, diabetic group
included 20 male patients suﬀered from type 2 diabetes mellitus and
the mixed group included 20 male patients suﬀered from both ische-
mic heart disease and type 2 diabetes mellitus. To all the studied sub-
jects the following was done: thorough history taking , physical
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examination, electrocardiogram , ultrasound “Doppler” examination,
plain X-ray and laboratory estimation of serum levels of : fasting and
post prandial glucose, urea, creatinine, uric acid , lipid proﬁle , cal-
cium (total and ionized) and inorganic phosphate,quantitative C-
reactive protein (CRP) , intact parathyroid and matrix carboxy glu-
tamic acid protein ( MGP) in addition to estimation of blood glycat-
ed hemoglobin .
Results: Doppler ultrasound showed increased values of the carotid
intima media thickness in the mixed group followed by the ischemic
and then the diabetic group and also detected vascular calciﬁcation
in the patients group. MGP level was signiﬁcantly higher in both the
ischemic and the mixed group than in the control groups . In addition,
diabetic patients with poor glycemic control showed signiﬁcantly
higher values of MGP when compared to diabetic patients with good
glycemic control and the control group.
Conclusion: The signiﬁcant increase of MGP level in the ischemic and
mixed groups than the control group reﬂects a compensatory mech-
anism to overcome the calciﬁcation process. In addition , its signiﬁ-
cant increase in patients with elevated HBA1c denotes that poor
glycemic control is a very strong, independent predictor of vascular
calciﬁcation.
http://dx.doi.org/10.1016/j.ehj.2013.12.041
Matrix metalloproteinase-9 (MMP9) and high sensitivity C – reactive
protein (hs-CRP) in coronary artery ectasia
W. Ammar a, M. Kappary a, Y. Baghdady a, M. Shehata b
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Objective: The speciﬁc causative mechanisms of abnormal luminar
dilatation in coronary artery ectasia (CAE) are essentially unknown.
Destruction of extracellular matrix may be responsible for the ectasia
formation. Thus, we investigated the role of matrix metalloproteinases
(MMP9), and inﬂammatory marker (high-sensitive C-reactive protein)
in CAE patients.
Methods: This study consisted of 30 consecutive CAE patients, 30
obstructive coronary artery disease (CAD) patients, and 20 controls
with normal coronary arteries undergoing cardiac catheterization.
Plasma levels of MMP-9, and hs-CRP were measured.
Results: Hs-CRP level was signiﬁcantly higher in the CAE group than
both in CAD and control groups (2.3 ± 0.5, 1.19 ± 0.54,
0.8 ± 0.3 mg/l, respectively , both p < 0:001), while , MMP-9 level
was signiﬁcantly higher in both CAE group and CAD than control
groups (27.71 ± 4.7, 25.2 ± 4.1 , 18.6 ± 3.3 ng/ml, respectively , both
p < 0:001). In subgroup analyses, MMP-9 level was signiﬁcantly
higher in CAE patients with multivessel involvement compared with
those with single-vessel ectasia (29.4 ± 3.1 vs. 25.2 ± 5.5 ng/ml,
P = 0.01), while hs CRP level was comparable in both groups
(2.3 ± 0.52 vs. 2.4 ± 0.45 ng/ml, P = 0.82).
Conclusion: Our results suggest that the increased levels of MMP-9,
hs-CRP may be responsible for ectasia formation in patients with
CAE and plasma level of MMP-9 is correlated with the severity of
CAE.
http://dx.doi.org/10.1016/j.ehj.2013.12.042
Prevalence of metabolic syndrome among adults in Suez Canal area
Fathi A H Maklady, Hanan M Kamal, Azza Z El-Eraky, Omar H
Hassouna
Cardiology Department, Suez Canal University, Egypt.
Introduction: The metabolic syndrome is a clustering of cardiovascular
risk factors, speciﬁcally, hypertension, diabetes, dyslipidemia and obes-
ity is increasingly being recognized as an important factor in the path-
ophysiology of atherosclerosis and as a target of therapy.
Objective: The aim of this work was to screen the prevalence of meta-
bolic syndrome in Suez Canal area among adults.
Subjects and methods: This study was conducted as a cross-sectional
study. 145 subjects Inhabitants of Suez Canal area were included into
this study. Detailed medical history with complete clinical examination
and laboratory analysis were performed to screen the metabolic syn-
drome (MS).
Results: 42.1% of the studied population had metabolic syndrome.
35.2% of the studied subjects were hypertensive and 33.8% of them
were diabetic. 64.1% of the studied subjects had a family history of dia-
betes and 61.4% of them had a family history of obesity. There were sig-
niﬁcantly higher mean of age, weight, BMI, waist circumference, SBP,
DBP, triglycerides and FBS among subjects with MS than subjects
without MS (p< 0.05), while there was signiﬁcantly lower mean of
HDL among subjects with MS than subjects without MS (p= 0.004).
Conclusion: The prevalence of Metabolic Syndrome of the studied
population is 42.1%.11% of studied population fulﬁlled ﬁve criteria
of metabolic syndrome .The majority of the studied subjects had
abdominal obesity (80.7%); obesity is more common in females than
males. Obesity is the major driver of MS.
Recommendation: Initiate, encourage and maintain intensive life style
modiﬁcations. Accurate and detailed assessments of the metabolic
syndrome in Egypt serve as base-line national data. Screening for
MS should be done as a national project in Egypt.
http://dx.doi.org/10.1016/j.ehj.2013.12.043
Mitral balloon valvotomy in pregnant women: Long-term follow-up
Mohamed Eid Fawzy.
Background and aim of the study: The study aim was to examine the
long-term outcome (nine years) of mitral balloon valvotomy in preg-
nant patients with severe mitral stenosis.
Methods: Twenty-three patients with severe, symptomatic (NYHA
class III/IV) mitral stenosis underwent material balloon valvotomy
using an lnoue balloon technique during the second trimester of
their pregnancy; mean follow up was 5.1 ± 2.8 year (range:
1–9 years).
Results: The procedure was successful in all patients. Immediately
after valvotomy, the Doppler-derived mitral valve area increased from
0.90 ± 0.18 to 1.97 ± 0.36 cm2 (p< 0.0001), and the transmitral
mean gradient decreased from ‘15.7 ± 4.7 to 5.5 ± 1.6 mmHg
(p< 0.0001). Four patients had mild worsening of mitral regurgita-
tion, and six developed insigniﬁcant interatrial communication imme-
diately after valvotomy. There was no other morbidity or mortality.
Patients showed a signiﬁcant improvement in mean NYHA class
Twenty-two patients had normal deliveries; one cesarean section in
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